Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Adocia

Market Cap 87.19M 101M 80.29M 75.38M 142M 9.57B 143M 949M 370M 4.68B 380M 372M 16.23B P/E Ratio 2025
-7.44x
P/E Ratio 2026 * 18x
Enterprise Value 44.67M 51.83M 41.13M 38.62M 72.51M 4.9B 73.28M 486M 189M 2.4B 195M 190M 8.32B EV / Sales 2025
31.9x
EV / Sales 2026 * 1x
Free-Float
90.83%
Yield 2025 *
-
Yield 2026 * -
1 day-6.11%
1 week+3.26%
Current month-15.32%
1 month-13.86%
3 months-28.34%
6 months-34.92%
Current year-37.64%
1 week 4
Extreme 4
4.71
1 month 3.9
Extreme 3.9
5.18
Current year 3.9
Extreme 3.9
7.45
1 year 3.46
Extreme 3.465
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 80 2012-02-23
Director/Board Member 58 2013-06-17
Date Insider Type Main position Quantity % Market Cap.
25-02-26Buy

Founder

109,170 0.6972%
24-04-05Buy

Founder

15,576 0.1105%
24-04-05Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-5.84%+3.26%+8.24%+5.51% 101M
+1.32%+0.39%+62.01%+112.72% 54.54B
-1.22%+5.01%+43.38%+36.69% 43.86B
-1.43%+3.47%-15.83%-20.48% 22.63B
-1.99%-3.55%-5.97%+377.60% 20.7B
-0.53%+0.54%+16.19%-36.06% 15.84B
+3.13%0.00%+11.59%-39.14% 14.83B
-1.70%-1.68%+24.79%+172.92% 13.1B
-5.17%+0.50%+21.80% - 12.66B
+0.29%+5.10%+75.82%+105.33% 11.56B
Average -1.34%+1.16%+24.20%+79.45% 20.98B
Weighted average by Cap. -0.48%+0.18%+31.97%+88.47%

Financials

2025 2026 *
Net sales 38.39M 44.55M 35.35M 33.19M 62.32M 4.21B 62.98M 418M 163M 2.06B 167M 164M 7.15B 38.39M 44.54M 35.35M 33.19M 62.31M 4.21B 62.97M 418M 163M 2.06B 167M 164M 7.15B
Net income -13.01M -15.1M -11.98M -11.25M -21.13M -1.43B -21.35M -142M -55.17M -699M -56.67M -55.47M -2.42B 3.98M 4.61M 3.66M 3.44M 6.45M 436M 6.52M 43.27M 16.86M 214M 17.32M 16.95M 740M
Net Debt -42.52M -49.34M -39.16M -36.76M -69.02M -4.66B -69.75M -463M -180M -2.28B -185M -181M -7.92B -48.77M -56.59M -44.91M -42.16M -79.16M -5.35B -79.99M -531M -207M -2.62B -212M -208M -9.08B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
77
Date Price Change Volume
26-06-17 4.190 -5.84% 154,112
26-06-16 4.450 +1.14% 279,380
26-06-15 4.400 +2.80% 217,308
26-06-12 4.280 +3.73% 255,817
26-06-11 4.126 +1.98% 125,806
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.450EUR
Average target price
13.00EUR
Spread / Average Target
+192.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!